Works matching Mayo Clinic Cancer Center

Results: 915
    1
    2
    3

    Long-term follow-up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU)

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 10, p. 1004, doi. 10.1002/ajh.24824
    By:
    • Witzig, Thomas E.;
    • Johnston, Patrick B.;
    • LaPlant, Betsy R.;
    • Kurtin, Paul J.;
    • Pederson, Levi D.;
    • Moore Jr, Dennis F.;
    • Nabbout, Nassim H.;
    • Nikcevich, Daniel A.;
    • Rowland, Kendrith M.;
    • Grothey, Axel
    Publication type:
    Article
    4
    5

    Proceedings—targeting carcinogenesis: Transduction, transcription, translationHeld in Rochester, Minnesota on October 6–7, 2005, the meeting was a jointly sponsored program of the Hormel Institute and the Mayo School of Continuing Medial Education. Financial sponsors included the Hormel Institute, Mayo Clinic Cancer Center, Merck, Hormel Foods Company, American Institute for Cancer Research, Licor, Pediatric Pharmaceuticals, Pfizer, Cell Signaling and Sarstedt.

    Published in:
    Molecular Carcinogenesis, 2006, v. 45, n. 6, p. 353, doi. 10.1002/mc.20227
    By:
    • Zigang Dong;
    • Ann M. Bode
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01310-z
    By:
    • Parrondo, Ricardo D.;
    • Das, Saurav;
    • Sledge, Hanna;
    • Bergsagel, Leif;
    • Fonseca, Rafael;
    • Leung, Nelson;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Elliott, Jamie;
    • Fernandez, Andre;
    • Flott, Caitlin;
    • Chanan-Khan, Asher A.;
    • Roy, Vivek;
    • Ailawadhi, Sikander
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Retroperitoneal involvement with light chain amyloidosis- case series and literature review.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 2, p. 316, doi. 10.1080/10428194.2020.1832670
    By:
    • Vaxman, Iuliana;
    • Visram, Alissa;
    • Pasvolsky, Oren;
    • Kumar, Shaji;
    • Dispenzieri, Angela;
    • Buadi, Francis;
    • Dingli, David;
    • Lacy, Martha;
    • Hayman, Suzanne;
    • Kyle, Robert;
    • Kapoor, Prashant;
    • Leung, Nelson;
    • Gonsalves, Wilson;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Gertz, Morie
    Publication type:
    Article
    35
    36

    Pathway polygenic risk scores (pPRS) for the analysis of gene-environment interaction.

    Published in:
    PLoS Genetics, 2025, v. 21, n. 8, p. 1, doi. 10.1371/journal.pgen.1011543
    By:
    • Gauderman, W. James;
    • Fu, Yubo;
    • Queme, Bryan;
    • Kawaguchi, Eric;
    • Wang, Yinqiao;
    • Morrison, John;
    • Brenner, Hermann;
    • Chan, Andrew;
    • Gruber, Stephen B.;
    • Keku, Temitope;
    • Li, Li;
    • Moreno, Victor;
    • Pellatt, Andrew J.;
    • Peters, Ulrike;
    • Samadder, N. Jewel;
    • Schmit, Stephanie L.;
    • Ulrich, Cornelia M.;
    • Um, Caroline;
    • Wu, Anna;
    • Lewinger, Juan Pablo
    Publication type:
    Article
    37
    38
    39
    40

    The impact of the California state lockdown during the COVID‐19 pandemic on management of patients with pancreatic ductal adenocarcinoma.

    Published in:
    Journal of Surgical Oncology, 2024, v. 130, n. 2, p. 276, doi. 10.1002/jso.27695
    By:
    • Oviedo, Parisa;
    • Burns, Shohei;
    • Chen, Wen‐Pin;
    • Mandl, Hanna K.;
    • Rosso, Claudia;
    • Radgoudarzi, Niloofar;
    • Crosetti, Anna;
    • Zamora, Steven;
    • Perry, Lauren M.;
    • Bold, Richard J.;
    • Labora, Amanda N.;
    • Donahue, Timothy R.;
    • Maker, Ajay;
    • Valerin, Jennifer B.;
    • Zell, Jason A.;
    • White, Rebekah R.
    Publication type:
    Article
    41

    The impact of the California state lockdown during the COVID‐19 pandemic on management of patients with pancreatic ductal adenocarcinoma.

    Published in:
    Journal of Surgical Oncology, 2024, v. 130, n. 2, p. 276, doi. 10.1002/jso.27695
    By:
    • Oviedo, Parisa;
    • Burns, Shohei;
    • Chen, Wen‐Pin;
    • Mandl, Hanna K.;
    • Rosso, Claudia;
    • Radgoudarzi, Niloofar;
    • Crosetti, Anna;
    • Zamora, Steven;
    • Perry, Lauren M.;
    • Bold, Richard J.;
    • Labora, Amanda N.;
    • Donahue, Timothy R.;
    • Maker, Ajay;
    • Valerin, Jennifer B.;
    • Zell, Jason A.;
    • White, Rebekah R.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48

    Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer.

    Published in:
    NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00606-2
    By:
    • Jayaraman, Swaathi;
    • Wu, Xinyan;
    • Kalari, Krishna R.;
    • Tang, Xiaojia;
    • Kuffel, Mary J.;
    • Bruinsma, Elizabeth S.;
    • Jalali, Shahrzad;
    • Peterson, Kevin L.;
    • Correia, Cristina;
    • Kudgus, Rachel A.;
    • Kaufmann, Scott H.;
    • Renuse, Santosh;
    • Ingle, James N.;
    • Reid, Joel M.;
    • Ames, Matthew M.;
    • Fields, Alan P.;
    • Schellenberg, Matthew J.;
    • Hawse, John R.;
    • Pandey, Akhilesh;
    • Goetz, Matthew P.
    Publication type:
    Article
    49
    50

    Response to Mitr and Pollack.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2022, v. 114, n. 12, p. 1729, doi. 10.1093/jnci/djac133
    By:
    • Wickland, Daniel P;
    • Sherman, Mark E;
    • Radisky, Derek C;
    • Mansfield, Aaron S;
    • Asmann, Yan W
    Publication type:
    Article